A Decomposed Fourier-Motzkin Elimination Framework to Derive Vessel Capacity Models

Accurate Vessel Capacity Models (VCMs) expressing thetrade-off between different container types that can be stowed on containervessels are required in core liner shipping functions such as uptake-,capacity-, and network management. Today, simple models based on volume,weight, and refrigerated container capacity are used for these tasks,which causes overestimations that hamper decision making. Though previouswork on stowage planning optimization in principle provide finegrainedlinear Vessel Stowage Models (VSMs), these are too complexto be used in the mentioned functions. As an alternative, this papercontributes a novel framework based on Fourier-Motzkin Eliminationthat automatically derives VCMs from VSMs by projecting unneededvariables. Our results show that the projected VCMs are reduced byan order of magnitude and can be solved 20–34 times faster than theircorresponding VSMs with only a negligible loss in accuracy. Our frameworkis applicable to LP models in general, but are particularly effectiveon block-angular structured problems such as VSMs. We show similarresults for a multi-commodity flow problem

Metabolism within the tumor microenvironment and its implication on cancer progression: an ongoing therapeutic target

Since reprogramming energy metabolism is considered a new hallmark of cancer, tumor metabolism is again in the spotlight of cancer research. Many studies have been carried out and many possible therapies have been developed in the last years. However, tumor cells are not alone. A series of extracellular components and stromal cells, such as endothelial cells, cancer-associated fibroblasts, tumor-associated macrophages and tumor-infiltrating T cells, surround tumor cells in the so-called tumor microenvironment. Metabolic features of these cells are being studied in deep in order to find relationships between metabolism within the tumor microenvironment and tumor progression. Moreover, it cannot be forgotten that tumor growth is able to modulate host metabolism and homeostasis, so that tumor microenvironment is not the whole story. Importantly, the metabolic switch in cancer is just a consequence of the flexibility and adaptability of metabolism and should not be surprising. Treatments of cancer patients with combined therapies including anti-tumor agents with those targeting stromal cell metabolism, anti-angiogenic drugs and/or immunotherapy are being developed as promising therapeutics.Mª Carmen Ocaña is recipient of a predoctoral FPU grant from the Spanish Ministry of Education, Culture and Sport. Supported by grants BIO2014-56092-R (MINECO and FEDER), P12-CTS-1507 (Andalusian Government and FEDER) and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras" is an initiative from the ISCIII (Spain). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript